volume 5 issue 5 pages 839-848

Intracellular Processing of Riboflavin in Human Breast Cancer Cells

Publication typeJournal Article
Publication date2008-08-29
scimago Q1
wos Q1
SJR0.968
CiteScore7.8
Impact factor4.5
ISSN15438384, 15438392
PubMed ID:  18754669
Drug Discovery
Pharmaceutical Science
Molecular Medicine
Abstract
A variety of polarized epithelial cells, such as human breast cancer (MCF-7), have mechanistically evolved the ability to adapt to the dynamic cellular environment and maintain homeostasis of an array of micronutrients which display conditional requirements. Active absorption mechanisms, including endocytosis, are able to control cell surface recognition and protein expression which are associated with a substance's intracellular processing and kinetics. Riboflavin (RF), or vitamin B2, has been recognized as an important factor in a multitude of terminal disease states, most notably in breast cancer, where its cellular absorption is significantly enhanced. In order to delineate the regulatory mechanisms and kinetics associated with RF control in human breast cancer tissue, this study aimed to model its absorption profile and identify its intracellular regulatory components. Using both the Michaelis-Menten equation and a modified version of it, incorporating both active internalization and passive diffusion, RF absorption displayed better correlation ( r (2) > 0.998) with the mixed, active and passive, model exhibiting kinetic parameters characteristic of a receptor-mediated uptake mechanism ( J max = 2.58 pmol/5 min, K m = 106 nM) at extracellular RF concentrations under 5 muM and a passive component existing at RF concentrations greater than 5 muM. Following internalization, RF was able to recycle back to the membrane with a half-life of 13.7 min at 37 degrees C, which occurred more rapidly with increasing extracellular RF concentrations ( t 1/2 = 5.4 min at 1 muM) and decreasing temperatures ( t 1/2 = 6.4 min at 4 degrees C). Furthermore, modification to endosomal pH using the lysomotropic agents monensin (25 muM) and primaquine (300 muM) significantly inhibited the exocytosis of RF (61 and 30% of control), whereas biochemical modification of endocytic trafficking with okadaic acid (1 muM) led to a significant increase in RF exocytosis (208%). In conclusion, RF homeostasis in MCF-7 cells is a well regulated process which is dependent upon RF concentration, temperature, and endosomal acidification.
Found 
Found 

Top-30

Journals

1
2
International Journal of Molecular Sciences
2 publications, 6.25%
Scientific Reports
2 publications, 6.25%
International Journal of Pharmaceutics
2 publications, 6.25%
Oncotarget
1 publication, 3.13%
Cancers
1 publication, 3.13%
Frontiers in Pharmacology
1 publication, 3.13%
Nano Research
1 publication, 3.13%
Pharmaceutical Research
1 publication, 3.13%
PLoS ONE
1 publication, 3.13%
Biomaterials
1 publication, 3.13%
Chemosphere
1 publication, 3.13%
Food and Chemical Toxicology
1 publication, 3.13%
Advanced Materials
1 publication, 3.13%
Photochemistry and Photobiology
1 publication, 3.13%
Langmuir
1 publication, 3.13%
Bioconjugate Chemistry
1 publication, 3.13%
Molecular Biology
1 publication, 3.13%
Critical Reviews in Food Science and Nutrition
1 publication, 3.13%
Artificial Cells, Nanomedicine and Biotechnology
1 publication, 3.13%
Nanomedicine and Nanotoxicology
1 publication, 3.13%
Journal of Pharmacy and Pharmacology
1 publication, 3.13%
ACS applied materials & interfaces
1 publication, 3.13%
Pharmaceutics
1 publication, 3.13%
Mendeleev Communications
1 publication, 3.13%
Frontiers in Bioscience - Elite
1 publication, 3.13%
ACS Applied Bio Materials
1 publication, 3.13%
Food Frontiers
1 publication, 3.13%
BioNanoScience
1 publication, 3.13%
1
2

Publishers

1
2
3
4
5
6
Springer Nature
6 publications, 18.75%
Elsevier
5 publications, 15.63%
Wiley
5 publications, 15.63%
MDPI
4 publications, 12.5%
American Chemical Society (ACS)
4 publications, 12.5%
Taylor & Francis
2 publications, 6.25%
Impact Journals
1 publication, 3.13%
Frontiers Media S.A.
1 publication, 3.13%
Public Library of Science (PLoS)
1 publication, 3.13%
Pleiades Publishing
1 publication, 3.13%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 3.13%
IMR Press
1 publication, 3.13%
1
2
3
4
5
6
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
32
Share
Cite this
GOST |
Cite this
GOST Copy
Bareford L. M. et al. Intracellular Processing of Riboflavin in Human Breast Cancer Cells // Molecular Pharmaceutics. 2008. Vol. 5. No. 5. pp. 839-848.
GOST all authors (up to 50) Copy
Bareford L. M., Phelps M. A., Foraker A. B., Swaan P. W. Intracellular Processing of Riboflavin in Human Breast Cancer Cells // Molecular Pharmaceutics. 2008. Vol. 5. No. 5. pp. 839-848.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1021/mp800046m
UR - https://doi.org/10.1021/mp800046m
TI - Intracellular Processing of Riboflavin in Human Breast Cancer Cells
T2 - Molecular Pharmaceutics
AU - Bareford, Lisa M.
AU - Phelps, Mitch A
AU - Foraker, Amy B
AU - Swaan, Peter W.
PY - 2008
DA - 2008/08/29
PB - American Chemical Society (ACS)
SP - 839-848
IS - 5
VL - 5
PMID - 18754669
SN - 1543-8384
SN - 1543-8392
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2008_Bareford,
author = {Lisa M. Bareford and Mitch A Phelps and Amy B Foraker and Peter W. Swaan},
title = {Intracellular Processing of Riboflavin in Human Breast Cancer Cells},
journal = {Molecular Pharmaceutics},
year = {2008},
volume = {5},
publisher = {American Chemical Society (ACS)},
month = {aug},
url = {https://doi.org/10.1021/mp800046m},
number = {5},
pages = {839--848},
doi = {10.1021/mp800046m}
}
MLA
Cite this
MLA Copy
Bareford, Lisa M., et al. “Intracellular Processing of Riboflavin in Human Breast Cancer Cells.” Molecular Pharmaceutics, vol. 5, no. 5, Aug. 2008, pp. 839-848. https://doi.org/10.1021/mp800046m.